These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1784045)

  • 41. An evaluation of fibrinolytic therapy of pulmonary thromboembolism using non-invasive examinations and the relationship of urokinase dosage to clinical outcome and coagulation-fibrinolytic changes.
    Oguma Y; Hasegawa H; Kawakami Y
    Jpn Circ J; 1988 Feb; 52(2):131-8. PubMed ID: 3361699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The evaluation of the therapeutic effect on acute myocardial infarction by radioisotope method--assessment of the intravenous injection of urokinase and comparison with the results of PTCR + PTCA].
    Yamazaki J; Kawamura Y; Okuzumi I; Morishita T; Ohsawa H; Yabe Y; Saito T; Kamishima G
    Kaku Igaku; 1989 Jun; 26(6):743-52. PubMed ID: 2796001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracoronary thrombolysis with urokinase in acute myocardial infarction. Effects on reperfusion and left ventricular wall motion.
    Cernigliaro C; Sansa M; Campi A; Sante Bongo A; Rossi P
    G Ital Cardiol; 1982; 12(5):365-73. PubMed ID: 6759286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
    Bode C; Schoenermark S; Schuler G; Zimmermann R; Schwarz F; Kuebler W
    Am J Cardiol; 1988 May; 61(13):971-4. PubMed ID: 2452564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prehospital thrombolysis in acute myocardial infarction.
    Schofer J; Büttner J; Geng G; Gutschmidt K; Herden HN; Mathey DG; Moecke HP; Polster P; Raftopoulo A; Sheehan FH
    Am J Cardiol; 1990 Dec; 66(20):1429-33. PubMed ID: 2251987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized study.
    Sun Y; Liu X; Guo L; Pang W; Guo X; Sun Z; Li Z; Cui X; Li H; Tao G; Wang L; Zhou C; Liu Y; Shan H; Wang M; Liu M; Li J; Yin L; Hu D
    Int J Cardiol; 2014 Mar; 172(2):326-31. PubMed ID: 24525155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
    Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
    Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on effect of shenmai injection in protecting myocardium against ischemia-reperfusion injury in thrombolytic therapy with urokinase for acute myocardial infarction patients evaluated by 99mTc-MIBI myocardial imaging].
    Guo SP; Zhang YZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Feb; 21(2):108-10. PubMed ID: 12577392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Electrocardiographic indices of reperfusion and limitation of the necrotic area in acute myocardial infarct].
    Traina M; Rotolo A; Lombardo R; Trapani R; Barranca P; Hoffmann E; Raineri AA
    Cardiologia; 1990 Sep; 35(9):721-6. PubMed ID: 2091824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
    François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
    Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
    Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of intracoronary and intravenous urokinase in acute myocardial infarction.
    Cernigliaro C; Sansa M; Campi A; Bongo AS; Carfora A; Rossi P
    G Ital Cardiol; 1984 Nov; 14(11):927-30. PubMed ID: 6526208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study on the reperfusion rate of acute myocardial infarction affected by inspiring nitric oxide and resolving thrombus intravenously before admission].
    Sun LD; Tang YL; Xi WB; Zhang N; Zhang YZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):169-71. PubMed ID: 15009968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrinolytic therapy urokinase for myocardial infarction.
    Nakano M
    Angiology; 1983 Oct; 34(10):654-73. PubMed ID: 6625222
    [No Abstract]   [Full Text] [Related]  

  • 55. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
    Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
    Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical experience with urokinase in intracoronary thrombolysis.
    Cernigliaro C; Sansa M; Campi A; Bongo AS; Rossi P
    Clin Cardiol; 1987 Apr; 10(4):222-30. PubMed ID: 3581531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
    Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
    J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled trial of urokinase in myocardial infarction. A European Collaborative Study.
    Lancet; 1975 Oct; 2(7936):624-6. PubMed ID: 52001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
    Collen D; Van de Werf F
    Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.